AstraZeneca (AZN.L) News and Global Pharmaceutical & Healthcare Updates

12,766
214.00
1.65 %
Daily range
Weekly range
  • Viktoras Karapetjanc
  • 4 hours ago
AZN slides as overbought conditions cap upside
AstraZeneca (AZN) stock is trading at GBX12,766, reflecting a decline of 1.65% on the day. The price is positioned above its key short- and medium-term moving averages, ...
  • Oleksii Zaichenko
  • Yesterday
Amgen lung cancer combo shows survival gain in late-stage trial
Late-stage trial results suggest Amgen may strengthen Imdelltra's commercial prospects in small cell lung cancer by pairing it with AstraZeneca's Imfinzi. The study shows the combination cuts the ...
  • Anton Kharitonov
  • 23.10.2026
Ultomiris and ZEGFROVY approvals lift AstraZeneca stock as buyer support prevails
AstraZeneca (AZN) stock is trading at GBX12,928, up 2.49% for the session. The price is holding above its key short- and medium-term moving averages, reflecting broad ...
  • Andrey Mastykin
  • 23.10.2026
AstraZeneca stock rises 2.4% as nine-month and third-quarter 2026 results
AstraZeneca will provide its nine-month and third-quarter 2026 performance update to investors on 30 October. The stock is up 2.4% on the day at GBX12,928.AstraZeneca will release its nine-month ...
  • Viktoras Karapetjanc
  • 22.10.2026
AstraZeneca stock trades flat as buyers maintain support despite mixed momentum signals
AstraZeneca (AZN) stock is trading at GBX12,626, showing a marginal gain on the day and continuing to hold above its key short- and medium-term moving averages while ...
  • Sholanke Dele
  • 21.10.2026
AstraZeneca secures Phase 3 Tezspire success: AZN gains momentum
AstraZeneca (AZN) stock is trading at GBX12,586 today, marking a 1.5% gain for the session and opening with a 40-point up gap. The price remains above its short- and ...
  • Anastasiia Chabaniuk
  • 20.10.2026
AstraZeneca stock outlook: Consolidation expected as range-bound trading dominates
AstraZeneca (AZN) stock is trading at GBX12,390 today, reflecting a slight decline for the session. The price is currently positioned below its key short-term averages ...
  • Viktoras Karapetjanc
  • 19.10.2026
AstraZeneca shares technical analysis: Downward price move meets GBX12,344 support
AstraZeneca (AZN) stock is trading at GBX12,430, down 2.11% on the day. The share price is currently positioned below its key short- and long-term moving averages but ...
  • Oleg Tkachenko
  • 16.10.2026
AstraZeneca shares technical analysis: Upward price move confirms strong near-term momentum
AstraZeneca (AZN) stock is trading at GBX12,698, up 3.24% on the day. Shares are positioned above their key short- and medium-term moving averages, suggesting near-term ...
  • Daria Chernytska
  • 15.10.2026
AstraZeneca strikes AI drug discovery deal with insitro worth up to $1.5 billion
AstraZeneca is expanding its use of artificial intelligence in early-stage research through a new collaboration with insitro focused on hard-to-treat liver and heart diseases. The agreement ...
  • Viktoras Karapetjanc
  • 15.10.2026
AstraZeneca gets China nod for Datroway: Can AZN sustain its upward rally?
AstraZeneca (AZN) stock is trading at GBX12,320, up 3.56% on the day. The shares are positioned above their key short- and medium-term moving averages, reflecting ...
  • Ivan Andriyenko
  • 14.10.2026
AstraZeneca shares technical analysis: Downward move persists as seller pressure dominates
AstraZeneca (AZN) stock is trading at GBX11,906 after slipping modestly on the day. The shares are positioned below their key moving averages, reflecting ongoing ...
  • Andrey Mastykin
  • 13.10.2026
AstraZeneca stock consolidates amid mixed clinical trial results and new oncology partnership
AstraZeneca (AZN) stock is trading at GBX11,976 after a modest decline in the latest session. It sits below its key moving averages, reflecting a broadly negative ...
  • Viktoras Karapetjanc
  • 12.10.2026
Why is AstraZeneca stock up today? Summit $2B funding and GBX12,030 resistance test
AstraZeneca (AZN) stock is trading at GBX12,024, reflecting a daily rise of 1.11%. The current price is situated below its key moving averages on short-term timeframes ...
  • Jainam Mehta
  • 09.10.2026
AstraZeneca stock price prediction: GBX11,694 support under pressure
AstraZeneca (AZN) stock is trading at GBX11,902, having closed lower by 2.28% for the session. The price sits below its key moving averages, reflecting downward pressure ...
  • Ashutosh Sureka
  • 08.10.2026
AZN rallies as Summit Therapeutics investment completes
AstraZeneca (AZN) stock is trading at GBX12,166, up 1.74% for the day. The price is currently positioned above its key moving averages, reflecting near-term ...
  • Oleg Tkachenko
  • 07.10.2026
AstraZeneca stock forecast: Breakout attempt eyes GBX12,282 resistance
AstraZeneca (AZN) stock is trading at GBX11,924 after rising 1.36% on the day, recovering some ground but remaining below its key moving averages, which highlights ...
  • Ashutosh Sureka
  • 06.10.2026
AstraZeneca stock support test at GBX11,258: Technical outlook
AstraZeneca (AZN) stock is trading at GBX11,738 after slipping 1.11% for the session. The shares remain below key short- and long-term moving averages, reflecting ...
  • Andrey Mastykin
  • 05.10.2026
Support test at GBX11,401: Can AstraZeneca stock avoid deeper losses?
AstraZeneca (AZN) stock is trading at GBX11,848, down 1.53% for the day. The price remains below its key moving averages, indicating ongoing short-term and long-term ...
  • Aleksandra Chaikina
  • 02.10.2026
AstraZeneca shares hold bearish bias after Summit Therapeutics investment news
AstraZeneca (AZN) stock is trading at GBX12,054, closing down 1.84% on the day after a gap lower and ending near its intraday lows. The shares remain under pressure, ...
  • Mira Kyivska
  • 01.10.2026
Kura Oncology stock seen rising on leukemia drug sales and pipeline potential
Kura Oncology is drawing renewed investor attention as it shifts further into the commercial stage with an approved leukemia treatment and a broader oncology pipeline. JPMorgan says early sales ...